News
MedInvest is hosting a Biotech and Pharma Investor Conference March 31-April 1, 2026 in New York City. NIH’s Steve Ferguson and Michael Salgaller will be speaking. They will be discussing NIH as a premier technology transfer partner, how the process at the NIH works, and answering questions! This is
The National Institute of Dental and Craniofacial Research (NIDCR) at the NIH has a great non-exclusive license opportunity available to commercialize a novel adeno-associated virus termed “44-9” (AAV44-9) vector for gene therapy. AAV44-9 based vectors have high gene transfer activity in many cell
Attend the FLC’s Using Valuations in Technology Transfer webinar to hear from NIH Office of Technology Transfer’s (OTT’s) Steve Ferguson on why using valuations is a good start to gathering information needed at various stages of technology transfer. Topics covered include why valuation is needed
Comirnaty®, colloquially known as the Pfizer vaccine, is a messenger RNA (mRNA) vaccine indicated for active immunization to prevent COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This vaccine by BioNTech/Pfizer received full FDA approval on August 23, 2021, after